ased on management's current
preliminary expectations and are subject to risks and uncertainties, which
may cause the Company's results to differ materially and adversely from the
statements contained herein. Some of the potential risks and uncertainties
that could cause actual results to differ from the results predicted
include, without limitation, commercial and governmental reimbursement
decisions, compliance and regulatory risks, the Company's ability to hire
personnel and manage its growth and the competitive landscape within our
industry. These and other risks and uncertainties are detailed in the
Company's annual report on Form 10-K for the full-year period ended
December 31, 2007 that was filed with the United States Securities and
Exchange Commission on February 12, 2008 and in subsequent filings with the
SEC. Undue reliance should not be placed on forward-looking statements,
which speak only as of the date they are made. Genoptix undertakes no
obligation to update any forward-looking statements to reflect new
information, events or circumstances after the date they were made, or to
reflect the occurrence of unanticipated events.
[Financial tables follow]
GENOPTIX, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except par value)
March 31, December 31,
2008 2007
(unaudited)
Assets
Current assets:
Cash and cash equivalents $31,933 $50,624
Investment securities available-for-sale 52,729 34,836
Accounts receivable, net of allowance for
doubtful accounts 15,213 9,013
Other current assets 1
'/>"/>
SOURCE Genoptix, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 Related medicine news :1.
Genoptix, Inc. Announces Pricing for Initial Public Offering2.
Genoptix, Inc. to Announce Fourth Quarter and Full Year 2007 Financial Results on February 12, 20083.
Genoptix Reports Strong Financial Results for the Fourth Quarter and Full Year 20074.
Genoptix Announces Filing of Registration Statement for Secondary Public Offering of Common Stock5.
Genoptix Announces Pricing of Secondary Public Offering6.
Genoptix Announces Participation at Cowen and Company 28th Annual Health Care Conference7.
Genoptix Announces Participation at Lehman Brothers 11th Annual Global Health Care Conference8.
Genoptix Announces 2008 Annual Stockholders Meeting and Date of Record9.
Genoptix Announces Participation at the Bank of America 2008 Healthcare Conference10.
New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites11.
Haemacure Reports Third Quarter 2007 Results